Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Toxoplasmosis - Overview
Toxoplasmosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Toxoplasmosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Toxoplasmosis - Companies Involved in Therapeutics Development
AbbVie Inc
GSK plc
PGTx Ltd
Tiba Biotech LLC
Vaxino SE
Toxoplasmosis - Drug Profiles
Monoclol Antibodies for Ocular Toxoplasmosis - Drug Profile
Product Description
Mechanism Of Action
pyrimethamine - Drug Profile
Product Description
Mechanism Of Action
Recombint Vector Vaccine for Protozoal Infection - Drug Profile
Product Description
Mechanism Of Action
Small Molecules for Toxoplasmosis - Drug Profile
Product Description
Mechanism Of Action
Small Molecules for Toxoplasmosis - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Inhibit CDPK1 for Protozoal Infections - Drug Profile
Product Description
Mechanism Of Action
toxoplasmosis [type II delta KU80 RH strain] vaccine - Drug Profile
Product Description
Mechanism Of Action
toxoplasmosis vaccine - Drug Profile
Product Description
Mechanism Of Action
toxoplasmosis vaccine - Drug Profile
Product Description
Mechanism Of Action
Toxoplasmosis - Dormant Projects
Toxoplasmosis - Product Development Milestones
Featured News & Press Releases
Dec 07, 2021: FTC, States to recoup millions in relief for victims fleeced by ?Pharma Bro’ scheme to illegally monopolize life-saving drug Daraprim
Apr 15, 2020: Oakrum Pharma announces the launch of Toxo Total Care patient services program to support Pyrimethamine 25mg tablets
Mar 31, 2020: Optime Care announces availability Of 25mg Pyrimethamine tablets for patients diagnosed with toxoplasmosis
Mar 11, 2020: Oakrum Pharma announces the launch of Pyrimethamine 25mg tablets in the United States
Feb 03, 2020: FDA grants approval of Daraprim drug’s first generic to Cerovene
Jan 27, 2020: FTC and NY Attorney General charge Vyera Pharmaceuticals, Martin Shkreli, and other defendants with anticompetitive scheme to protect a list-price increase of more than 4,000 percent for life-saving drug Daraprim
Feb 03, 2016: Turing Pharmaceuticals Provides Key Facts to Congressiol Oversight Committee
Jan 22, 2016: Turing Pharmaceuticals to Testify at Congressiol Hearing on Drug Pricing
Dec 18, 2015: Continued Availability of Daraprim (pyrimethamine)
Nov 24, 2015: Texas Becomes Latest State ADAP to Add Daraprim (pyrimethamine) to Formulary
Oct 13, 2015: Turing Pharmaceuticals Announces Improvements in Daraprim Accessibility and Affordability
Sep 25, 2015: Keller Rohrback Investigates Turing Pharmaceuticals for Alleged Daraprim Price Gouging
Sep 24, 2015: Turing Pharmaceuticals Issues Statement on Daraprim Price Reduction
Sep 18, 2015: Turing Pharmaceuticals Provides Update On Availability Of Daraprim
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Toxoplasmosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Toxoplasmosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Toxoplasmosis - Pipeline by AbbVie Inc, 2022
Toxoplasmosis - Pipeline by GSK plc, 2022
Toxoplasmosis - Pipeline by PGTx Ltd, 2022
Toxoplasmosis - Pipeline by Tiba Biotech LLC, 2022
Toxoplasmosis - Pipeline by Vaxinano SE, 2022
Toxoplasmosis - Dormant Projects, 2022
Toxoplasmosis - Dormant Projects, 2022 (Contd..1)